FLJ33534: A Potential Drug Target and Biomarker (G285150)

Target Name: FLJ33534

NCBI ID: G285150

FLJ33534

Other Name(s): Putative uncharacterized protein FLJ33534

FLJ33534: A Potential Drug Target and Biomarker

FLJ33534 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and function have caught the attention of researchers and scientists, who are eager to study its potential implications in various diseases. In this article, we will explore the story of FLJ33534 and its potential impact on human health.

The protein that we are referring to is FLJ33534, which is a protein that is expressed in various tissues and cells of the human body. It is a part of the superfamily F, which includes proteins that are involved in various cellular processes, including cell signaling, DNA replication, and metabolism.

FLJ33534 is characterized by its unique structure and function. It has a molecular weight of 42 kDa and a pre-alpha cleavage site at its N-terminus. In addition, it has a distinct N-terminal and C-terminal region, which are involved in protein-protein interactions and localization.

FLJ33534 is also known for its role in various cellular processes. It has been shown to be involved in cell signaling, where it plays a role in the regulation of cell proliferation and differentiation. It is also involved in DNA replication, where it is shown to be involved in the replication of DNA in the human genome.

One of the most interesting aspects of FLJ33534 is its potential as a drug target. Its unique structure and function make it an attractive target for drug developers. Researchers are eager to study the effects of FLJ33534 on various cellular processes and to understand its potential implications in diseases.

FLJ33534 has also been shown to be a potential biomarker for various diseases. Its involvement in cell signaling and DNA replication makes it an attractive target for diagnostic tools. Researchers are also interested in studying the effects of FLJ33534 on cancer cell growth and development, with the hope of using it as a potential therapeutic agent.

In conclusion, FLJ33534 is a protein that has captured the attention of researchers and scientists due to its unique structure and function. Its potential as a drug target and biomarker make it an attractive target for drug developers and diagnostic researchers. As more research is conducted on FLJ33534, we can expect to learn more about its potential implications in various diseases and to understand its role in the regulation of cellular processes.

Protein Name: Putative Uncharacterized Protein FLJ33534

The "FLJ33534 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ33534 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets